Clinical trials are underway to assess the effects of CAR-T cell therapy for treating breast cancer, including CAR-T cells recognizing epithelial cell adhesion molecule (EpCAM) (NCT02915445), cleaved MUC1 (NCT04020575, NCT02792114), and ROR1 (NCT05274451). Here, EPCAM is linked to breast cancer.